Soluble Neprilysin　― Cardiac Function and Outcome in Hypertrophic Cardiomyopathy ―

Background: Circulating soluble neprilysin (sNEP) predicts outcome in heart failure (HF) patients with reduced ejection fraction (EF), but not in those with preserved EF. We examined sNEP in patients with hypertrophic cardiomyopathy (HCM), and their correlations with other biomarkers, cardiac functi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Circ Rep
Päätekijät: Yoshihisa, Akiomi, Yokokawa, Tetsuro, Ichijo, Yasuhiro, Kimishima, Yusuke, Kanno, Yuki, Misaka, Tomofumi, Sato, Takamasa, Oikawa, Masayoshi, Kobayashi, Atsushi, Yamaki, Takayoshi, Sugimoto, Koichi, Kunii, Hiroyuki, Takeishi, Yasuchika
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Japanese Circulation Society 2019
Aiheet:
Original article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889477/
https://ncbi.nlm.nih.gov/pubmed/33693148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-19-0034
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia